We are live on ! Find out more
SIA

Sit Investment Associates Portfolio holdings

AUM $4.93B
1-Year Est. Return 12.22%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+12.22%
3 Year Est. Return
+41.16%
5 Year Est. Return
+31.78%
10 Year Est. Return
+136.16%
AUM
$5.77B
AUM Growth
-$254M
Cap. Flow
-$320M
Cap. Flow %
-5.55%
Top 10 Hldgs %
18.38%
Holding
461
New
36
Increased
100
Reduced
232
Closed
35

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$53.7M
2
WMT icon
Walmart Inc
WMT
+$47.9M
3
GD icon
General Dynamics
GD
+$44.6M
4
WHR icon
Whirlpool
WHR
+$43.4M
5
GILD icon
Gilead Sciences
GILD
+$40.2M

Sector Composition

Rank Sector Weight
1 Healthcare 17.38%
2 Industrials 11.91%
3 Technology 11.79%
4 Consumer Discretionary 9.7%
5 Financials 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1
Medtronic
MDT
$109B
$142M 2.46%
1,819,126
+443,571
+32% +$33.6M
AAPL icon
2
Apple
AAPL
$4.54T
$119M 2.07%
3,840,288
-12,700
-0.3% -$383K
HON icon
3
Honeywell
HON
$77B
$116M 2%
1,232,375
+84,413
+7% +$7.73M
HD icon
4
Home Depot
HD
$331B
$115M 1.99%
1,011,288
-21,117
-2% -$2.33M
MSFT icon
5
Microsoft
MSFT
$3.45T
$102M 1.77%
2,515,240
-168,315
-6% -$7.33M
PEP icon
6
PepsiCo
PEP
$190B
$102M 1.77%
1,066,190
-28,485
-3% -$2.76M
VZ icon
7
Verizon
VZ
$195B
$97.3M 1.69%
2,001,120
-142,950
-7% -$6.9M
JNJ icon
8
Johnson & Johnson
JNJ
$618B
$93.9M 1.63%
933,018
-129,927
-12% -$13.2M
JPM icon
9
JPMorgan Chase
JPM
$935B
$91M 1.58%
1,502,170
-69,590
-4% -$4.12M
CVS icon
10
CVS Health
CVS
$133B
$82.6M 1.43%
800,600
-64,485
-7% -$6.52M
AVGO icon
11
Broadcom
AVGO
$1.85T
$77.9M 1.35%
6,134,700
-887,900
-13% -$10.2M
INTC icon
12
Intel
INTC
$455B
$76.5M 1.33%
2,445,475
+193,775
+9% +$6.54M
CAH icon
13
Cardinal Health
CAH
$53.9B
$68.6M 1.19%
760,260
+20,920
+3% +$1.8M
PFE icon
14
Pfizer
PFE
$143B
$67.9M 1.18%
2,056,807
+268,064
+15% +$8.52M
M icon
15
Macy's
M
$6.53B
$67.2M 1.16%
1,035,070
+16,005
+2% +$1.03M
PG icon
16
Procter & Gamble
PG
$336B
$64.3M 1.11%
784,365
-28,950
-4% -$2.49M
STJ
17
DELISTED
St Jude Medical
STJ
$63.2M 1.1%
966,250
+3,800
+0.4% +$253K
BDX icon
18
Becton Dickinson
BDX
$45.6B
$63.2M 1.1%
451,026
-35,234
-7% -$4.93M
TWX
19
DELISTED
Time Warner Inc
TWX
$62.6M 1.08%
741,340
-153,140
-17% -$12.7M
UNH icon
20
UnitedHealth
UNH
$376B
$59.4M 1.03%
502,250
+25,215
+5% +$2.8M
GILD icon
21
Gilead Sciences
GILD
$162B
$58.3M 1.01%
594,395
+396,255
+200% +$40.2M
SNA icon
22
Snap-on
SNA
$21.2B
$57.8M 1%
393,285
-41,026
-9% -$5.77M
TJX icon
23
TJX Companies
TJX
$174B
$56.5M 0.98%
1,612,210
-527,652
-25% -$18M
ZTR
24
Virtus Total Return Fund
ZTR
$340M
$55.2M 0.96%
4,034,600
-249,637
-6% -$3.45M
ZBH icon
25
Zimmer Biomet
ZBH
$18.2B
$54.8M 0.95%
480,243
-29,148
-6% -$3.33M

Similar funds

Sit Investment Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Sit Investment Associates held 461 positions worth $5.77B, down 4.2% from $6.02B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Sit Investment Associates withdrew a net $320M in Q1 2015, closing 35 positions and reducing 232 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $44.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sit Investment Associates opened a new position in AbbVie worth $52M.

  • Sit Investment Associates's largest Q1 2015 buy was AbbVie: 888,791 shares worth $52M.
  • Sit Investment Associates added most to Gilead Sciences in Q1 2015, an estimated $40.2M increase.
  • Sit Investment Associates's biggest Q1 2015 reduction was Qualcomm, cutting an estimated $46.7M.
  • Sit Investment Associates fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $44.2M.
  • Sit Investment Associates's ten largest holdings make up 18% of its $5.77B portfolio in Q1 2015.
  • Sit Investment Associates opened 36 new positions and closed 35 in Q1 2015.
  • Sit Investment Associates's portfolio value fell 4.2% quarter-over-quarter to $5.77B.

Based on Sit Investment Associates's 13F filing for Q1 2015, filed 30 Apr 2015.